Fundraising Fox
/Companies
Sign in

Epiodyne

San Francisco, US · Founded 2016 · Delaware corporation · 4 known investors

Find your way into Epiodyne

Sign up to see every warm intro you have to Epiodyne

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Epiodyne team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Epiodyne develops small-molecule opioids designed to optimize therapeutic outcomes, with initial focus on safer pain relief and improved opioid use disorder treatment with reduced addiction and respiratory depression risk. The company uses a platform approach to tune drug candidates across a spectrum from inhibitors to full agonists.

BiotechHealthtechMedical Devices

Founders & leadership

Epiodyne was founded in 2016 by Brian Shoichet.

BS
Brian ShoichetFounder
DCDouglas Crawford, Ph.D.
Douglas Crawford, Ph.D.CEO
DGDon Gehlert, Ph.D.
Don Gehlert, Ph.D.Head of BiologyDon Gehlert, Ph.D., led research teams at Eli Lilly that contributed multiple clinical candidates including Strattera, an ADHD medication, and has published extensively on neuropharmacology, neuropeptides, and neurological disease areas including depression, substance abuse, and obesity. He currently serves as Chief Scientific Officer for both MindMed and Epiodyne.

Board

DCDouglas Crawford
Douglas CrawfordBoard directorManaging General Partner at Mission Biocapital

Investors · 4

Mission Bay Capitallisted by Mission Bay CapitalSan Francisco
Mission Biocapitallisted by Mission BiocapitalSan Francisco · $500K

How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us

Kleiner PerkinsinferredMenlo Park · $500K – $15Mvia Brook Byers · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$14.3M disclosed across 3 rounds · 2016–2018

▶$8MraisedApr 2019 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alex TkachenkoExecutive Officer, Director
  • Brook ByersDirector
  • Douglas CrawfordDirector
Offering amount
$8M
Amount sold
$8M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.8MraisedNov 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brook ByersDirector
  • Douglas CrawfordDirector
  • Alex TkachenkoExecutive Officer, Director
Offering amount
$10.1M
Amount sold
$5.8M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedJun 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas CrawfordExecutive Officer, Director
  • Brian ShoichetDirector
Offering amount
$500K
Amount sold
$500K
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Team - Epiodyneepiodyne.comAbout - Epiodyneepiodyne.com

Frequently asked questions

What does Epiodyne do?
Epiodyne develops small-molecule opioids designed to optimize therapeutic outcomes, with initial focus on safer pain relief and improved opioid use disorder treatment with reduced addiction and respiratory depression risk. The company uses a platform approach to tune drug candidates across a spectrum from inhibitors to full agonists.
Who founded Epiodyne?
Epiodyne was founded by Brian Shoichet in 2016.
Who are Epiodyne's investors?
Epiodyne's investors include Menlo Ventures, Mission Bay Capital, Mission Biocapital, Kleiner Perkins.
How much funding has Epiodyne raised?
Epiodyne has disclosed $14.3M raised across 3 rounds.
Where is Epiodyne headquartered?
Epiodyne is headquartered in San Francisco, US.